FDA approves label updates for BMS’ CAR T cell therapies
These updates for Breyanzi and Abecma reduce patient monitoring requirements and removes REMS.
Therapy Area
Viatris gains China approval for Yupelri to treat COPD
Novo Nordisk teams up with WeightWatchers in latest telehealth push
Why can’t the US figure out weight loss drug prices?
Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies
Vor Bio back from brink with autoimmune drug deal rising to $4bn
BioCity’s SC0062 gains NMPA breakthrough therapy designation
UK steps up with £1.25bn Gavi vaccine pledge as US funding disappears
